NCL Method PCC-22
Residual Organic Solvent Analysis in Nanoformulations Using Headspace Gas Chromatography
Listed in Datasets | publication by group NCL Protocols
Version 1.0 - published on 12 Sep 2022 doi:10.17917/QFEP-HD46 - cite this
Licensed under these terms
Description
Various organic solvents are used in the synthesis of complex drug products (for example, nanomedicines) and in the manufacturing/purification of drug substances and other excipients. Residual organic solvents may originate from the purification of drug materials and cleaning/maintenance of equipment used to manufacture the drug products. These residual organic solvents are considered drug product impurities having no therapeutic benefit. High or inconsistent concentrations of these volatile residual impurities not only pose health risks for patients but also affect the product’s quality. In addition, residual organic solvents can affect the physicochemical properties of therapeutics, such as particle size, dissolution and wettability.
Content List
NCL_Method_PCC-22.pdf(PDF | 515 KB)
Cite this work
Researchers should cite this work as follows:
- Kattel, K., Jeffrey Clogston (2022). NCL Method PCC-22. NCI Hub. doi:10.17917/QFEP-HD46
Tags
NCL Protocols
This publication belongs to the NCL Protocols group.
When watching a publication, you will be notified when a new version is released.